大明王朝1566

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

A |     (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。

B |     8月25日消息，今日，梅耶·马斯克在社交平台X上分享了自己在上海购物、就餐以及城市观光的日常。    随后，其儿子埃隆·马斯克在评论区跟帖盛赞上海，表示：“上海是一座很棒的城市，强烈推荐前往游览。”    

    母子二人接连发声，也再次引发海外网友对中国城市和旅游体验的关注。    

    值得一提的是，距离两人上一次在社交平台“点赞中国”，仅过去两周。

C |     8月11日，埃隆·马斯克曾在X上发文称：“中国太棒了，我强烈推荐大家去看看。”     

    随后，梅耶·马斯克转发该帖并表示，中国每个城市都有各自的魅力和不同的文化景点，建筑和街道干净整洁，人们彬彬有礼、勤奋努力、相互尊重。

D |     她还特别提到，自己在中国旅行时感到安全，所以很享受来中国。    据央视财经报道，在此次上海之行期间，梅耶·马斯克还接受了总台财经频道专访。    

    谈及埃隆此前那条“推荐大家来中国”的帖子，梅耶表示：“埃隆发自内心喜爱中国，所以把这份感受分享出来。看到那条推文的时候，我心想，我去过的中国城市可比他多多了！”     梅耶透露，近年来自己多次来华工作、旅行，已经到访过中国14座城市。

E |     在她看来，中国各地都充满活力，安全便利的城市环境以及热情有礼的民众，都给她留下了深刻印象，她也乐于通过社交平台向世界分享自己在中国的所见所感。    梅耶表示：“中国到处都充满活力与机遇。”在她看来，中国的发展速度很快，也让她每次到访都能发现新的变化和惊喜。    “中国到处都充满活力与机遇，”她表示，中国的发展速度让她每次来都有新惊喜。         

Current article:http://ft3mc3z.cibianpangjujiusu.cyou/kx06t/20260826/3894.html

Published on:05:26:57